University of Las Palmas de Gran Canaria, Department of Psychiatry, Insular University Hospital of Gran Canaria, The Canary Islands, Spain.
Service of Mental Health, General Management of Healthcare Programs, The Canary Islands Health Service, Research Network on Health Services for Chronic Conditions (REDISSEC), Carlos III Health Institute, Department of Psychiatry, The Canary Islands, Insular University Hospital of Gran Canaria, Spain.
Compr Psychiatry. 2021 Jul;108:152240. doi: 10.1016/j.comppsych.2021.152240. Epub 2021 Apr 17.
Despite a wealth of studies seeking to identify factors associated with nonadherence few consistent predictors have been determined, and several gaps still exist in the literature.
We assessed 110 consecutively admitted patients diagnosed with schizophrenia or schizoaffective disorder according to ICD-10 criteria. Assessments were performed during hospitalization and at six-months follow-up. Evaluation included sociodemographic, clinical, psychopathologic and treatment-related variables. Prevalence of nonadherence, associated variables, reasons for nonadherence and possible subtypes were explored. Adherence was defined as the concurrence of adherence to antipsychotic treatment and adherence to outpatient follow-up, during the six-month period.
Nonadherence was detected in 58.2% of patients. An identifiable profile was found in nonadherent patients. After multivariate logistic regression analysis, low socio-economic level (OR = 3.68; 95% CI = 1.42-9.53), current cannabis use or abuse (OR = 2.79; 95% CI = 1.07-7.28), nonadherence as a reason for relapse and admission (OR = 5.46; 95% CI = 2.00-14.90), and greater overall severity of symptoms at six months follow-up (OR = 2.00; 95% CI = 1.02-3.95) remained independently associated with nonadherence. Believing that medication is unnecessary was the most reported reason for nonadherence. For nonadherent patients (N = 64), two distinguishable subtypes were found: intentional nonadherence (N = 32; 50%), and unintentional nonadherence (N = 32; 50%).
A large percentage of patients with schizophrenia or schizoaffective disorder did not adhere to their treatment in the post-discharge follow-up period. The profile identified may enable better prevention of this problem. Specific reasons for nonadherence should also be explored to provide individualized strategies.
尽管有大量研究试图确定与不依从相关的因素,但很少有一致的预测因素被确定,文献中仍存在一些空白。
我们评估了 110 名连续入院的符合 ICD-10 标准的精神分裂症或分裂情感障碍患者。评估在住院期间和六个月随访期间进行。评估包括社会人口学、临床、精神病理学和治疗相关变量。探讨了不依从的患病率、相关变量、不依从的原因和可能的亚型。在六个月的时间里,依从性被定义为同时遵循抗精神病治疗和门诊随访的治疗。
58.2%的患者存在不依从。在不依从的患者中发现了一个可识别的特征。经过多变量逻辑回归分析,社会经济水平低(OR = 3.68;95%CI = 1.42-9.53)、当前使用或滥用大麻(OR = 2.79;95%CI = 1.07-7.28)、不依从是复发和入院的原因(OR = 5.46;95%CI = 2.00-14.90)以及六个月随访时总体症状严重程度较高(OR = 2.00;95%CI = 1.02-3.95),与不依从独立相关。认为药物不必要是不依从的最常见原因。对于不依从的患者(N = 64),发现了两种可区分的亚型:故意不依从(N = 32;50%)和非故意不依从(N = 32;50%)。
很大一部分精神分裂症或分裂情感障碍患者在出院后随访期间没有坚持治疗。确定的特征可能有助于更好地预防这一问题。还应探讨不依从的具体原因,以提供个性化的策略。